Skip to main navigation Skip to search Skip to main content

International, Multicenter, Study of Twenty-Eight Week, Open Label, Titrated Oral Lixivaptan Administration in patients with Chronic Hyponatremia Extension to Studies CK-LX 3401, 3405, and 3430

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/1006/30/12

Funding

  • Cardiokine Biopharma, LLC: $8,778.87